Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

Senseonics is planning to launch its 365-day continuous glucose monitor (CGM) in 4Q24.

The Germantown, MD-based company announced the launch plans for the Eversense 365 CGM and maintained its full-year guidance of $ 22 million to $24 million during a recent earnings call.